However, in ITSEMs, the elevated TfR2 expression in the absence of TfR1 may also suggest a compensatory mechanism in response to impaired iron metabolism, potentially driving tumor progression and malignancy through atypical activation of TfR2 pathways. Here, TFR2 is linked to neoplasm.